These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38947313)

  • 1. Identification and experimental validation of cuproptosis regulatory program in a sepsis immune microenvironment through a combination of single-cell and bulk RNA sequencing.
    Zhao T; Guo Y; Li J
    Front Immunol; 2024; 15():1336839. PubMed ID: 38947313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic stratification of sepsis through DNA damage response based RiskScore system: insights from single-cell RNA-sequencing and transcriptomic profiling.
    Lin Q; Zeng R; Yang J; Xu Z; Jin S; Wei G
    Front Immunol; 2024; 15():1345321. PubMed ID: 38404591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer.
    Li L; Sun F; Kong F; Feng Y; Song Y; Du Y; Liu F; Kong X
    Front Oncol; 2023; 13():1083956. PubMed ID: 37384293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of single-cell and bulk RNA seq to reveal the prognostic model and tumor microenvironment remodeling mechanisms of cuproptosis-related genes in colorectal cancer.
    Chu B; Wang Y; Yang J; Dong B
    Aging (Albany NY); 2023 Dec; 15(23):14422-14444. PubMed ID: 38078879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Analysis of Cuproptosis-Related Genes in Prognosis and Immune Infiltration of Hepatocellular Carcinoma Based on Bulk and Single-Cell RNA Sequencing Data.
    Yang C; Guo Y; Wu Z; Huang J; Xiang B
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Key platelet genes play important roles in predicting the prognosis of sepsis.
    Shen L; Tao C; Zhu K; Cai L; Yang S; Jin J; Ren Y; Xiao Y; Zhang Y; Lai D; Tou J
    Sci Rep; 2024 Oct; 14(1):23530. PubMed ID: 39384856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
    Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.
    Zhou Y; Xiao D; Jiang X; Nie C
    J Transl Med; 2023 Jan; 21(1):28. PubMed ID: 36647156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell and bulk RNA-seq unveils the immune infiltration landscape associated with cuproptosis in cerebral cavernous malformations.
    Chen C; Bao Y; Ju S; Jiang C; Zou X; Zhang X; Chen L
    Biomark Res; 2024 Jun; 12(1):57. PubMed ID: 38835051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel molecular subtypes and a signature to predict prognosis and therapeutic response based on cuproptosis-related genes in prostate cancer.
    Zhang J; Jiang S; Gu D; Zhang W; Shen X; Qu M; Yang C; Wang Y; Gao X
    Front Oncol; 2023; 13():1162653. PubMed ID: 37205181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
    Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and Immunological Significance of the Molecular Subtypes and Risk Signatures Based on Cuproptosis in Hepatocellular Carcinoma.
    Tang X; Ren X; Huang T; Miao Y; Ha W; Li Z; Yang L; Mi D
    Mediators Inflamm; 2023; 2023():3951940. PubMed ID: 37124062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
    Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
    J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma.
    Tian XM; Xiang B; Yu YH; Li Q; Zhang ZX; Zhanghuang C; Jin LM; Wang JK; Mi T; Chen ML; Liu F; Wei GH
    Front Immunol; 2022; 13():999849. PubMed ID: 36211401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
    Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
    Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.